viewProactive Group

Anavex Life Sciences shares pop on trial results for Anavex 2-73 treatment for Parkinson’s disease

Up to 80% of Americans with Parkinson's will eventually experience PDD, a type of dementia related to Alzheimer’s

A researcher at Anavex Life Sciences Corp working in the lab on new therapies
The biopharma firm’s shares jumped in pre-market trade

Anavex Life Sciences Corp. (NASDAQ:AVXL) announced on Tuesday that the biopharma company is planning to initiate a Phase 2 clinical trial of its ANAVEX 2-73 treatment for Parkinson’s disease dementia (PDD), which is a type of dementia related to Alzheimer's disease.

Anavex Life Sciences jumped nearly 8.5% in pre-market trade.

“As many as 80% of people with Parkinson’s will experience Parkinson’s disease dementia and treatment options are limited,” said Christopher U Missling, CEO of Anavex Life Sciences Corp.

Read: Globo to participate in high-profile Parkinson's Disease project

“We are excited to progress our program to Phase 2, with a focus on the many patients with Parkinson’s disease dementia, and we remain focused on the discovery and development of potential treatments for neurological diseases with unmet needs, including Alzheimer’s disease and Rett syndrome.”

Parkinson's disease is a common neurological disorder in older adults, estimated to affect nearly 2% of people older than 65.

The Parkinson's Foundation estimates that 1 million Americans have the disease

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


First Mining Gold to acquire East Cedartree claims to bolster its Cameron...

First Mining Gold Corp (TSE:FF) (OTCQX:FFMGF) CEO Dan Wilton tells Proactive the group has added more resource ounces and consolidated its ground at the Cameron Gold project in northwest Ontario, by purchasing the East Cedartree claims from Metalore Resources (CVE:MET). Wilton says the...

7 hours, 9 minutes ago

2 min read